Can children with hyperlipidemia receive ketogenic diet for medication-resistant epilepsy?

Yeou-Mei Christiana Liu1, Helen Lowe, Maria M Zak

  • 1Department of Pediatrics, Division of Neurology, The Hospital for Sick Children, Toronto, Ontario, Canada. christiana.liu@sickkids.ca

Journal of Child Neurology
|February 22, 2013
PubMed

Insights

The ketogenic diet, while potentially worsening lipids initially, significantly improved cholesterol and lipoprotein levels in children with hyperlipidemia over 12 months. This suggests the diet can help control lipid levels in both children and adults.

Area of Science:

  • Pediatric Endocrinology
  • Nutritional Science
  • Cardiovascular Health

Background:

  • The ketogenic diet, characterized by very-high fat content, is known to potentially exacerbate lipid profiles in individuals with pre-existing hyperlipidemia.
  • This diet increases serum lipoproteins and decreases antiatherogenic high-density lipoproteins, posing a risk for cardiovascular health.

Purpose of the Study:

  • To evaluate the impact of the ketogenic diet on lipid profiles in children with pre-existing hyperlipidemia.
  • To assess the long-term effects of ketogenic diet treatment on total cholesterol, low-density lipoprotein, and high-density lipoprotein levels.

Main Methods:

  • A retrospective chart review was conducted on 160 children treated with a ketogenic diet between September 2000 and May 2011.
  • Lipid levels (total cholesterol, low-density lipoprotein, triglycerides, high-density lipoprotein, and total cholesterol/high-density lipoprotein ratio) were measured pre-diet and at 3, 6, and 12 months post-initiation.

Main Results:

  • Twelve children with pre-existing hyperlipidemia were identified and analyzed.
  • Significant reductions in mean total cholesterol, low-density lipoprotein, and total cholesterol/high-density lipoprotein ratio were observed during ketogenic diet treatment.
  • Normalization of total cholesterol and low-density lipoprotein levels occurred in a majority of children by 12 months, with diet modifications aiding in achieving healthy lipid levels.

Conclusions:

  • The ketogenic diet, with appropriate modifications, can effectively control and normalize lipid levels in children diagnosed with hyperlipidemia.
  • Extrapolated data suggests potential efficacy in managing lipid levels for both pediatric and adult populations through ketogenic diet interventions.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...